1. Home
  2. COSM vs LEXX Comparison

COSM vs LEXX Comparison

Compare COSM & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.38

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.65

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COSM
LEXX
Founded
2009
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
18.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
COSM
LEXX
Price
$0.38
$0.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
934.4K
173.0K
Earning Date
11-17-2025
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,792,819.00
$522,000.00
Revenue This Year
$20.69
$13.35
Revenue Next Year
$53.10
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
6.69
5.05
52 Week Low
$0.28
$0.46
52 Week High
$1.32
$1.90

Technical Indicators

Market Signals
Indicator
COSM
LEXX
Relative Strength Index (RSI) 30.06 37.10
Support Level $0.35 $0.67
Resistance Level $0.47 $0.79
Average True Range (ATR) 0.04 0.07
MACD -0.01 -0.01
Stochastic Oscillator 15.72 4.85

Price Performance

Historical Comparison
COSM
LEXX

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: